HHTM

MILAN, ITALY — Amplifon announced it has received two international awards in design and user experience, with recognition from the UX Design Awards and the iF Design Awards for its OtoKiosk digital audiometer and Amplifon App. The solutions were developed by AmplifonX, the company’s research and development division. The UX Design Award was presented to OtoKiosk in the Product category.

EDEN PRAIRIE, MINNESOTA — Starkey announced that its flagship product, Omega AI, has received an AI Innovation Award from the Edge AI + Vision Alliance. The award recognizes products using edge AI and vision technologies that demonstrate innovation and meaningful market impact. The AI Innovation Awards highlight advancements across industries, including medical diagnostic devices and autonomous systems, and recognize the

What does it take to compete at the highest level of sport while growing up with hearing loss? In this conversation, U.S. ski jumper Estella Hassrick shares her journey—from being diagnosed with hereditary cochlear dysplasia at age three to competing on the U.S. national team. She discusses the realities of hearing loss in high-performance sports, including the challenges of wearing

PORTLAND, OREGON — New research from Oregon Health & Science University and Anhui University in China suggests that serotonin, a neurotransmitter commonly targeted by medications for depression and anxiety, may also play a role in worsening tinnitus symptoms. The study, published April 20 in the Proceedings of the National Academy of Sciences, found that elevated serotonin levels in the brain

WHITE BEAR LAKE, MINNESOTA — Envoy Medical, Inc. (NASDAQ: COCH) announced that all 56 participants enrolled in its pivotal clinical trial evaluating the fully implanted Acclaim® cochlear implant have completed their activation visits, marking a key milestone in the study timeline. The activation visit represents the point at which each participant’s device is turned on for the first time. “With

A newly published study in Nature Communications describes a novel robotic system designed to access the inner ear through a minimally invasive, transcanal approach—potentially opening the door to more precise diagnostics and targeted therapies for conditions such as hearing loss, tinnitus, and Ménière’s disease. The system, developed by Li and colleagues, integrates navigation, visualization, and microsurgical tools into a compact,

TARRYTOWN, NEW YORK — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Otarmeni™ (lunsotogene parvec-cwha), marking the first gene therapy approved for a genetic form of hearing loss. The approval represents a significant milestone for a field that has been steadily advancing in recent years. As previously discussed in

Miracle-Ear conventions used to be raucous affairs, and their 2005 event in Huntington Beach, CA, was no exception. Beyond franchisees masquerading as USC Trojans while a Beach Boys cover band played hits from the early 1960s, one memorable moment from this conference sticks out for me: Robert Sweetow’s talk on something called “Listening and Communication Enhancement,” or LACE as he

Three-time world record holder and dementia advocate Louis Alexander is calling for greater awareness of earlier ear and hearing health checks, amid growing concern about the links between hearing loss and cognitive decline. Hearing loss is the top modifiable risk factor for dementia, according to The Lancet Commission. However, a new study of more than 1,000 people conducted by ear

AURORA, ILLINOIS — Phonak U.S. announced a new partnership with USA Pickleball as part of its nationwide “Hear to Win” campaign, an initiative focused on encouraging a more proactive approach to hearing health. The campaign aims to raise awareness of the role hearing plays in overall wellness, particularly in maintaining social connection and engagement. Through the partnership, Phonak will bring